In a cellular model of CF, ASOs were designed to target the inhibitory secondary mRNA structures in the uORF of the 5’ UTR on the CFTR mRNA transcript—effectively increasing both the expression and function of CFTR [88]. This evidence concerns the gene CFTR and cystic fibrosis.